Lunai Bioworks Plans Nasdaq Delisting After $9.02 Million Deficit

Trading in its common stock is expected to be suspended Oct. 30, with the delisting expected to take effect around Nov. 12.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.